Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms

(2016) P. G. Kluetz et al.   CLINICAL CANCER RESEARCH

Chemotherapy-induced neuropathy: A comprehensive survey

(2014) N.C. Miltenburg et al.   CANCER TREATMENT REVIEWS

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review

(2014) Floortje Mols et al.   SUPPORTIVE CARE IN CANCER

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

(2013) P. Alberti et al.   ANNALS OF ONCOLOGY

Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry

(2013) Floortje Mols et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

(2013) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention

(2012) W. Grisold et al.   NEURO-ONCOLOGY

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

(2012) Sherry L. Wolf et al.   SUPPORTIVE CARE IN CANCER

Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients

(2011) C. M. L. Driessen et al.   SUPPORTIVE CARE IN CANCER

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial

(2010) C. M. Ruland et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Model specification in oral health-related quality of life research

(2009) Jacobien M. Kieffer et al.   EUROPEAN JOURNAL OF ORAL SCIENCES

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

(2009) Kojiro Shimozuma et al.   SUPPORTIVE CARE IN CANCER

Use of health-related quality-of-life assessments in daily clinical oncology nursing practice

(2008) Doranne L. Hilarius et al.   CANCER